2023 annual financial data
Protara Therapeutics 2023 Operating margin
Direct answer
Operating margin was Not calculable.
Operating income was -43,613,000 USD and net income was -40,420,000 USD.
Operating cash flow was -37,557,000 USD.
Get free Protara Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -43,613,000 USD
- Net income
- -40,420,000 USD
- Operating cash flow
- -37,557,000 USD